Surveillance in Patients With Diffuse Large B Cell Lymphoma

Avyakta Kallam, Jayanth Adusumalli, James O. Armitage

Research output: Contribution to journalReview article

Abstract

With improvement in the cure rates for diffuse large B cell lymphoma, the question of surveillance imaging in patients who achieve complete remission after the initial therapy has become relevant. Some of the clinical practice guidelines recommend surveillance scanning. However, several studies have reported no benefit in overall survival with scans. Moreover, studies have highlighted an increased risk for developing secondary malignancies because of exposure to ionizing radiation from the scans. Different international societies have contrasting guidelines for the role of surveillance computerized tomography scans in patients who achieve complete remission after first-line therapy. Any benefit of surveillance imaging must be balanced by the costs, risk of radiation exposure, and lack of survival benefit. The PubMed platform was searched using relevant keywords for English-language articles with no date restrictions. Search terms were cross-referenced with review articles, and additional articles were identified by manually searching reference lists. Results were reviewed by the authors and selected for inclusion based on relevance. We present a review of this current data available for surveillance imaging in patients with diffuse large B cell lymphoma.

Original languageEnglish (US)
Pages (from-to)157-163
Number of pages7
JournalMayo Clinic Proceedings
Volume95
Issue number1
DOIs
StatePublished - Jan 2020

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Surveillance in Patients With Diffuse Large B Cell Lymphoma'. Together they form a unique fingerprint.

  • Cite this